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Abstract 
Biodegradability of graphene is one of the fundamental parameters determining the fate in vivo 
of this material. Here, two types of aqueous dispersible graphene, corresponding to single-layer 
(SLG) and few-layer graphene (FLG), devoid of either chemical functionalisation or stabilizing 
surfactants, were subjected to biodegradation by human myeloperoxidase (hMPO) mediated 
catalysis. Graphene biodegradation was also studied in the presence of activated, degranulating 
human neutrophils. The degradation of both FLG and SLG sheets was confirmed by Raman 
spectroscopy and electron microscopy analyses, leading to the conclusion that highly dispersed 
pristine graphene is not biopersistent. 
 
The biomedical applications of graphene family materials (GFMs) including graphene, graphene 
oxide (GO), reduced graphene oxide, FLG and graphene nanoribbons are attracting huge 
attention as ideal components for flexible biomedical electronic devices, implants or for drug 
delivery.
[1] 
In this context, biodegradation and biocompatibility are two important parameters for 
translating the use of GFMs in a clinical setting. Earlier studies revealed that the progress in the 
biomedical applications of GO is limited by some risks of toxicity and mutagenicity.
[2]
 Although 
biocompatibility can be modulated by covalent or non-covalent functionalisation, biodegradation 
of GFMs is strongly dependent on oxygen percentage, type of functional groups, defects, lateral 
size, and number of layers.
[3]
 Biodegradation of GFMs using peroxidases secreted by activated 
immune cells like neutrophils and eosinophils is one of the major route discovered so far,
[4]
 as 
demonstrated for oxidised CNTs
[4, 5]
 and GO.
[6, 7]
 Indeed, primary human neutrophils "sense" GO 
in a size-dependent manner and release so called neutrophil extracellular traps or NETs leading 
to degradation of the offending material.
[6-8]
 Biomedical applications of GO have been more 
widely explored,
[3]
 but some recent studies have shown promising results also for graphene. For 
example, we discovered that FLG dispersions displayed specific killing action on monocytes, 
showing neither toxic nor activation effects on the other immunocompetent cells. The unique 
ability of FLG to specifically trigger necrosis of monocytic cells, might be exploited to treat 
aggressive forms of myelomonocytic leukemia.
[9]
 
Recent results also proved that graphene can be exploited in neural interfaces and flexible 
devices.
[10, 11]
 However, in the applications as implantable devices or the use as drug delivery 
system via systemic administration, testing biodegradability or biopersistance of graphene should 
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be interrogated. Along this line, biodegradation of graphene with oxidative enzymes secreted by 
cells like neutrophils are very relevant, since this type of cells is the first immune barrier 
intervening in the case of inflammation. Herein, we study the biodegradation of two types of 
water dispersible graphene corresponding to FLG and SLG. The biodegradability of these 
materials was assessed in vitro using recombinant human myeloperoxidase (hMPO) and ex vivo 
using freshly isolated neutrophils releasing hMPO extracellularly. 
The intrinsic hydrophobicity of the graphene layers prohibits the production of stable graphene 
aqueous suspension. In the current study, we employed water dispersible FLG and SLG devoid 
of chemical functionalisation or surfactants to stabilise them in the aqueous media. FLG was 
produced by mechanochemical exfoliation of graphite thorough interaction with melamine by 
ball milling treatment in solvent free conditions.
[12]
 After the treatment, water was added to the 
solid and melamine was removed using dialysis. FLG was stabilised in water or phosphate buffer 
at 0.1 mg/ml with a final concentration of melamine below 1 ppm (Figure S1A).
[12]
 The obtained 
FLG powder was characterised using TEM, Raman spectroscopy, thermogravimetric and 
elemental analyses (Figure S2). FLG contains around 3.7% of oxygen, corresponding to the 
presence of few oxygenated groups as also observed by XPS.
[12]
 Raman analysis revealed that 
the defects are mostly localised at the edges of FLG sheets.
[12]
 
Homogeneously dispersed SLG was instead obtained by oxidising (i.e. electron removal by air 
exposure) a graphenide (negatively charged graphene, KC8) solution in tetrahydrofuran, mixing 
it with degassed water and evaporating the organic solvent to get water dispersed SLG (Figure 
S1B).
[13]
 SLG was characterised using TEM, Raman spectroscopy, XPS and elemental analysis 
(Figure S3). SLG is stable in water by a balance of weak inter-graphene sheet attractive forces 
and electrostatic repulsion due to spontaneous adsorption of OH
- 
ions (zeta potential = -45 mV at 
neutral pH) on the graphene surface obtained from graphenide oxidation.
[13]
 Raman analysis 
confirmed that SLG is a low-defect graphene due to presence of narrow D and G band linewidths 
and co-existence of few edge and sp
3
 defects due to some functionalisation of the flakes with -H 
and -OH.
[13]
 The elemental analysis also confirmed that SLG has about 3% of oxygen (Figure 
S3D).  
As both FLG (two to four layers) and SLG (monolayer) were obtained using completely different 
methods, their physicochemical properties are different, likely affecting their behaviour during 
the degradation process. 
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The two graphene samples were dispersed in phosphate buffer and treated with hMPO and H2O2 
for 40 h (see Experimental section in SI). The degradation of both graphene suspensions was 
carried out adding H2O2 every hour and replenishing hMPO every 5 h. The degradation of FLG 
and SLG was followed by analysing the graphene samples using TEM and Raman spectroscopy 
at different time-points. First, we employed TEM to visualise the morphological changes of FLG 
and SLG sheets before and after treatment with hMPO/H2O2 (Figure 1). After 25 h treatment, 
flat 2D nanosheets started to become porous, and numerous tiny nanopores were observed on the 
surface of FLG and their edges were highly crumpled (Figure 1B). In addition, some sheets lost 
their 2D shape (Figure 1C). Further significant changes were observed in the morphology of 
FLG sheets after 40 h, where highly porous residues were formed (Figure 1D) along with 
completely degraded material (Figure 1E). A few aggregated sheets were also found confirming 
the non-uniform degradation due to low-dispersibility of FLG in buffer (Figure S4A). We noted 
that addition of H2O2 alone did not affect the morphology of FLG even after 40 h (Figure 1F), 
confirming the strong oxidative nature of the intermediates formed during the enzymatic cycle of 
hMPO. 
 
Figure 1: TEM images of FLG. (A) FLG dispersed in phosphate buffer; after treating with 
hMPO (B-C) for 25 h; (D-E) after 40 h and (F) after treating with H2O2 in the absence of hMPO 
for 40 h. 
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Similar to the behaviour of FLG, significant differences in morphology were also evidenced for 
SLG after hMPO treatment (Figure 2). Treatment with the enzyme for 25 h drastically affected 
the structure of SLG (Figure 2B-C). Most of the sheets lost their flat shape leading to highly 
broken and porous sheets (Figure 2C). Prolonging the treatment to 40 h increased further the 
damages (Figure 2D-E), and most of the sheets were broken down to nanoscale fragment. Only 
a few partially degraded sheets were observed (Figure S4B). Importantly, the changes in the 
morphology of SLG sheets were more drastic compared to FLG after hMPO treatment, which 
could be explained with a better aqueous dispersibility and the presence of only single-layer 
graphene sheets in the SLG sample. Control treatment with H2O2 alone did not affect the 
structure of SLG, confirming that the degradation is due to the enzymatic action (Figure 2F). 
 
 
Figure 2: TEM images of SLG sheets: (A) dispersed in phosphate buffer; after treating with 
hMPO (B-C) for 25 h; (D-E) after 40 h and (F) after treating with H2O2 in the absence of hMPO 
for 40 h. 
 
 
Next, to complement the electron microscopy results, we employed Raman spectroscopy, which 
is a powerful tool to understand the changes in the structure, quantify the amount of defects and 
the oxidation level of graphene sheets.
[14]
 We calculated the intensity ratio of D and G bands that 
indicates the number of defects on the surface of graphene. Initially, the D/G intensity ratio of 
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FLG sheets dispersed in PBS was 0.51, which is similar to the value reported in the literature 
(Figure 3A).
[12]
 After incubation with hMPO for 25 h, the variation of this ratio was very small 
(D/G = 0.46). After 40 h, FLG sheets displayed two types of spectra. A series of averaged 
spectra presented well defined D and G bands (D/G = 0.41), while a second set of spectra were 
completely devoid of D bands and nearly missing G bands (Figure 3A). The drastic decrease of 
these two bands is due to significant oxidation/degradation of FLG sheets, as observed by TEM. 
Raman microspectrometric 2D mapping of FLG sample further confirmed the degradation 
(Figure S5). 
 
Figure 3: Raman analyses of (A) FLG sheets and (B) SLG sheets before and after treating with 
hMPO for 25 h and 40 h, respectively. 
 
Raman analyses of SLG sheets also showed a similar trend seen for FLG (Figure 3B). SLG 
sheets dispersed in PBS had a D/G ratio of 1.5.
[13, 15]
 The hMPO treatment for 25 h resulted in an 
increase of D/G ratio to 1.8, confirming the increase of defects or oxidation of graphene 
sheets.
[16]
 In addition, the intensities of D and G bands were reduced compared to control 
samples in PBS. Further, the D/G ratio slightly decreased to 1.42 after 40 h, and the intensities of 
D and G bands were significantly reduced compared early time points. It should be noted that the 
sample treated for 40 h showed two types of Raman signatures like FLG (Figure 3B). One set of 
spectra present still defined D and G bands while another series of spectra evidenced the 
disappearance of D and G bands, explaining the presence of completely degraded graphene 
sheets as shown by TEM analysis (Figure 2E). 2D mapping analysis again supported the 
degradation of SLG (Figure S6). This result also confirms that the degradation of SLG sheets by 
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hMPO is not completed even after 40 h unlike GO, that is entirely degraded within 24 h.
[6, 7]
 This 
kind of spectral changes was absent in control samples where FLG and SLG were treated only 
with H2O2 (Figure S7). 
It is not surprising that graphene is more resistant to enzymatic degradation than GO, as the 
number of defects and functional groups that are determinant factors for this process are 
negligible in comparison to those in GO. Overall, the Raman analyses did not support a complete 
degradation/oxidation of graphene sheets in contrast to the TEM analyses. This could be due to 
the aggregation of graphene sheets in PBS, which resulted in displaying two kinds of Raman 
signatures even after 40 h treatment, and the technical limitations of Raman, which does not 
allow to evidence the presence of the nanoscale and porous fragments. Overall, both Raman and 
TEM analyses confirmed that some of FLG and SLG sheets were only partially degraded, likely 
due to low dispersibility or aggregation of graphene sheets into thicker sheets as shown in 
Figure S4. We reported earlier that also aggregated GO sheets could not be degraded by 
hMPO.
[6]
 
To gain more insights about the interaction between hMPO and graphene samples, we decided to 
conduct an electrophoresis analysis. As shown in Figure S8, SLG displays better interaction 
with cationic hMPO (arginine rich protein) over FLG because of the high negative surface 
charge of SLG (zeta potential = -45 mV).
[13, 17]
 Thus, the enhanced interaction between SLG and 
hMPO could be the driving force for the higher degradability of SLG over FLG sheets (Figure 
2). We previously noted a similar trend in the hMPO-driven biodegradation of GO samples 
characterised by different surface charge.
[6]
 
Then, we wanted to assess if hMPO-rich human neutrophils were able to biodegrade FLG and 
SLG. Our previous works have demonstrated that neutrophils are capable to degrade GO and 
CNTs extracellularly upon degranulation of oxidative enzymes.
[7, 8, 18]
 The N-formyl-methionyl-
leucyl-phenylalanine (fMLP) tripeptide is a potent activator of neutrophils and cytochalasin B 
(Cyto-B) enhances several fMLP-stimulated neutrophil responses, including aggregation, 
superoxide production, and degranulation.
[19]
 Freshly isolated primary human neutrophils were 
activated with fMLP and Cyto-B and incubated with FLG and SLG. Neutrophils activated in this 
manner were added every day up to five days (Figure 4A). Exogenous H2O2 was not required, as 
these neutrophils already contain the complete system required for degradation.
[20]
 The 
biodegradation of the FLG and SLG was analysed by confocal Raman microspectrometric 
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mapping as shown in Figure 4B and 4C, respectively. FLG was significantly degraded after 5 
days, as indicated by the significant reduction of D and G band intensities (Figure 4B). 
 
  
Figure 4. (A) Schematic illustration showing the study design for activated polymorphonuclear 
leukocyte (PMN)-mediated FLG and SLG degradation. Raman microspectroscopic measurement 
of FLG (B) and SLG (C) samples following incubation with PMNs. 
 
 
This was confirmed by Raman 2D mapping analyses of FLG at different time-points, revealing 
again a remarkable reduction in the G band intensity after 5 days of treatment compared to day 0 
(Figure 5A). The D/G ratios instead increased along the days of incubation with neutrophils 
(Figure 5B and 5C) for both FLG and SLG, but at a lower extent for SLG. These D/G increases 
after 5 days confirmed that oxidation mediated degradation of the graphene sheets has 
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occurred.
[6, 7]
 In addition, the peak enlargement,
[21]
 leading to the lack of separation between the 
D and G bands for SLG (Figure 4C), together with the disappearance of the characteristic 2D 
band, further support a reduction of the degree of graphitization and the creation of defects on 
graphene sheets. 
  
Figure 5. (A) G band images of FLG samples at different time-points showing reduction in the 
G band intensity (scale bar: 4 and 9 µm). The D/G band ratio of FLG (B) and SLG (C) was 
increased with PMN incubation time indicating incorporation of greater defects due to 
degradation of the flakes. 
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Taken together, these results showed that activated primary human neutrophils can digest both 
FLG and SLG. SLG sheets were degraded at lower speed compared to FLG sheets by the 
neutrophils, likely due to the presence of minor number of defects and lower content of 
oxygenated functions on the surface of SLG sheets compared to FLG sheets. Since FLG was 
obtained by mechanical ball-milling and subsequent dispersion, whereas SLG sheets were 
synthesised by direct exfoliation in solution, a high quality graphene sheets is likely present in 
SLG.
[13]
 In comparison to isolated hMPO, the cellular system deployed here seems to be more 
efficient in degrading FLG than SLG. 
Overall, the treatment of graphene sheets  either in vitro in the presence of recombinant hMPO or 
using activated neutrophils, suggested that degradation of pristine graphene sheets is also 
possible, similarly to degradation of other carbon materials like oxidised CNTs or GO.
[4, 6, 7, 18]
 
Though FLG and SLG have only a slightly different oxygen content (~3.7% and 3%, 
respectively), they have different types of defects and functional groups at their edges. While 
FLG has some oxygenated groups like epoxides, carbonyl and carboxylates,
[12]
 SLG has defects 
derived from the modification of the edges by protons and hydroxyls. Overall, comparing the 
degradation of few-layer graphene to that of single-layer graphene based on their oxygen content 
remain difficult to rationalise. The degradation is triggered by the generation of reactive 
intermediates of hMPO in the presence of H2O2 and NaCl. In particular, the highly oxidant 
reactive intermediate hypochlorite (NaOCl, E
o 
= 1.56 V) is the main species able to oxidise and 
degrade the graphene sheets. In the case of GO, we found that the total degradation process 
encompasses 24 h.
[6, 7]
 Since graphene does not have oxygenated functional groups and defects 
like GO, we can expect that it would be more difficult to degrade pristine graphene sheets. 
Earlier studies dealing with in vivo and in vitro macrophage degradation of carboxyl 
functionalised graphene (graphene treated with HNO3) revealed that the degradation of this type 
of graphene is possible within cells, though the mechanism of degradation was not proven.
[22]
 In 
addition, our current study further reinforces the idea that pristine graphene is biodegradable, and 
shows for the first time that neutrophils are capable of extracellular digestion of graphene. 
Although the in vitro degradation and neutrophil degradation of FLG and SLG have shown some 
differences, the current results add another important element to the safety assessment of GFMs, 
with potential implications for their in vivo use. Previously, Schinwald et al. showed that 
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pulmonary exposure to pristine graphene nanoplatelets (average lateral dimension: 5 μm, average 
thickness: ~10 nm) significantly increased the number of neutrophils and eosinophils, 24 h post-
exposure compared to the control mice.
[23]
 The acute inflammation reaction in the lungs was 
reduced after 7 days presumably due to the degradation of graphene platelets into smaller 
fragments. Notably, the material was too large to be completely phagocytosed by macrophages 
and it stands to reason that extracellular digestion of these materials may come into play, along 
with other clearance mechanisms. Our results show that pristine graphene sheets, from single- to 
few-layers of a few hundred nanometers in lateral size, can be degraded by the action of 
activated neutrophils, albeit at a slower rate than GO,
[7]
 further supporting the potential of water 
dispersible graphene for biomedical applications. 
To summarise, we have demonstrated that graphene can be degraded either by recombinant 
hMPO or by hMPO secreted by activated neutrophils. Two different graphene samples, SLG and 
FLG, showed different degradability behaviour due to their different physicochemical properties, 
resulting from differences in the synthesis methods. These results clearly demonstrate that 
pristine graphene with minimum defects can be degraded by hMPO-mediated oxidation, 
indicating that our immune system has strategies to degrade graphene materials. 
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Materials and Methods 
Materials 
Human myeloperoxidase (hMPO) was obtained derived from human neutrophils (Athens 
Research and Technology, USA) with an activity of 180-220 U∙mg-1. Diethylenetriamine 
pentaacetic acid (DTPA), hydrogen peroxide (30% aqueous solution), NaCl, NaH2PO4∙2H2O and 
Na2HPO4∙2H2O were purchased from Alfa Aesar and used directly without any further 
purification. 
Degradation of graphene materials by hMPO 
The stock solution of exfoliated graphene is a surfactant-free single-layer graphene (SLG) 
dispersed in water (0.1 mg/mL). 125 µL of SLG solution was added to 325 µL of 50 mM 
phosphate buffer (140 mM NaCl + 100 µM DTPA, transition metal chelating agent), to this 
solution 50 µL of 50 µg of hMPO was added. The total volume of reaction mixture was 500 µL. 
A 2 µL of 50 mM H2O2 was added every hour. The final concentration of H2O2 was 200 µM. 
hMPO was renewed for every 5 h up to 40 h in total. The reaction mixture was maintained at 
37°C throughout experiment. The final concentration of SLG is 25 µg/mL. As pristine graphene 
sheets were assumed to be more resistant to oxidation compared to GO
[1]
 and carboxylated 
CNTs,
[2]
 their degradation was carried out up to 40 h in comparison to 24 h previously used for 
GO.
[1]
  
15 
 
Similar to the above experiment, 12.5 µg of few-layer graphene (FLG)
[3]
 lyophilized powder was 
dispersed in 450 µL of 50 mM phosphate buffer (140 mM NaCl + 100 µM DTPA, transition 
metal chelating agent). To this solution 50 µL of 50 µg of hMPO was added. The total volume of 
the reaction mixture was 500 µL. Two µL of 50 mM H2O2 was added every hour. The final 
concentration of H2O2 was 200 µM. hMPO was renewed for every 5 h up to 40 h. The reaction 
mixture was maintained at 37°C throughout the experiment. The final concentration of FLG was 
25 µg/mL. 
The control experiments treating FLG and SLG with H2O2 were also carried out in the absence of 
hMPO. Both graphene suspensions (25 µg/mL) were prepared in 50 mM phosphate buffer (140 
mM NaCl + 100 µM DTPA, transition metal chelating agent). The total volume of reaction 
mixture was 500 µL. 2 µL of 50 mM H2O2 was added every hour. The final concentration of 
hydrogen peroxide was 200 µM. 
The aliquots of treated graphene sheets (add volume) were taken for fixed time intervals, at 0 h, 
15 h, 24 h and 40 h and all the samples were stored at -15 °C in a dark room before analysis. 
Raman analyses 
Raman analysis of in vitro degraded samples was performed using Raman spectra Renishaw 
inVia microRaman equipped with 532 nm laser and a Leica microscope. All samples were 
prepared by drop-casting 10 µL of respective samples on silicon wafer coated with SiO2 (20 nm, 
TED Pella) and dried for 24 h at room temperature. All the spectra were recorded with 1% laser 
power (0.6 mW) using 100× objective lens. The results reported represent the averages of at least 
five individual spectra.  
Raman microspectrometric 2D mapping of in vitro degraded samples was also performed using 
Raman spectra Renishaw inVia microRaman equipped with 532 nm laser and a Leica 
microscope. All samples were prepared by drop-casting 10 µL of respective samples on silicon 
wafer coated with SiO2 (20 nm, TED Pella). The maps were recorded with 1% laser power (0.6 
mW) using 100× objective lens. The scan areas were selected according to the different samples 
in order to avoid, as far as possible, the zones without nanomaterial. One µm was the measure of 
the distance between the spectra. 
Raman analysis of ex vivo degraded samples was performed as previously described
[4, 5]
 using a 
confocal Raman microspectroscopy (WITec alpha300 system, Germany) with a laser of 532 nm 
wavelength set at an integration time of 0.5 s and 600× magnification. The scan area for each 
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sample was adjusted to 100×100 µm. For determination of the intensities of the D-band (second 
order double resonant mode activated by defects, ∼1354 cm-1) and G-band (tangential C–C 
stretching modes, ∼1582 cm-1). The Raman spectrum of each sample is an average of 10000 
spectra obtained from a scan size of 100 µm×100 µm. 
TEM analysis 
Six µL of each aliquot were deposited on carbon coated copper grid and dried under the lamp, 
and washed the grids in the Milli Q water for ~1 hour to remove the salts (from buffer). All the 
samples were analysed by a Hitachi H7500 microscope (Tokyo, Japan) with an accelerating 
voltage of 80 kV, equipped with a AMT Hamamatsu camera (Tokyo, Japan).  
Gel electrophoresis 
The immobilisation of hMPO on the surface of graphene sheets was evaluated by incubating 
hMPO with FLG and SLG at room temperature. Briefly, FLG and SLG and hMPO were allowed 
to interact by mixing together. For SLG, 8 µL of SLG (100 µg/mL in milli-Q water) and 5 µL of 
hMPO (1 µg/µL in phosphate buffer) and 7 µL of phosphate buffer were incubated for 30 
minutes. For FLG, 20 µL of FLG (40 µg/mL in milli-Q water) and 5 µL of hMPO (1 µg/µL in 
phosphate buffer) were incubated for 30 min. At the end of the incubation time, Laemmli buffer 
5 µL was added to the mixture and samples (30 µL) were loaded on a SDS-PAGE 4-15% 
precasted gel (BioRad). Gel electrophoresis was then run under non-reducing conditions to 
evaluate the stable electrostatic interaction between hMPO and graphene samples using a Mini-
PROTEAN II apparatus (BioRad) and applying a 150 V voltage during 40 min. After 
electrophoresis, gels were stained with Coomassie Blue (overnight at room temperature) and 
scanning densitometry was performed with a GS-800™  alibrate  Densitometer (BioRa ). The 
densitometry analysis was then performed using the ImageJ 1.48f software. Signal density was 
normalised to the hMPO density. 
Degradation of graphene materials by neutrophils 
Neutrophils were isolated from buffy coats of healthy human blood donors (Karolinska 
University Hospital, Stockholm, Sweden) as previously described.
[6]
 The samples are completely 
anonymized and for this reason no specific approval is required. Briefly, neutrophils were 
isolated from healthy donors every day for 5 consecutive days by density gradient centrifugation 
using Lymphoprep (Axis Shield, Oslo, Norway) followed by gradient sedimentation in a 5% 
dextran solution and hypotonic lysis of residual erythrocytes. To study degradation, freshly 
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isolated neutrophils (10
6
 cells/mL) were incubated in phenol red-free RPMI-1640 culture 
medium (Sigma Aldrich) supplemented with 2 mM L-glutamine, 100 U/mL penicillin and 100 
mg/mL streptomycin without serum and incubated in 5% CO2 at 37°C with FLG or SLG at 20 
µg/mL concentration in the presence of fMLP (10 nM) an  cytochalasin B (5 μg/mL) (Sigma 
Aldrich) to trigger degranulation.
[7]
 Freshly isolated, ex vivo activated neutrophils were added 
every day. Samples were collected at the indicated time-points and stored at -80 °C for further 
analysis. 
 
Figure S1: TEM images of (A) FLG and (B) SLG dispersed in phosphate buffer, respectively. 
Scale bar: 500 nm. 
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Figure S2: (A) TEM revealed a lateral size distribution of FLG in water dispersion between 200 
and 1000 nm, with most of nanosheets around 300 nm. Panel (B) shows Raman average 
spectrum from FLG, which is composed by the typical graphene Raman bands: G peak, D peak 
and 2D band, which are centered at ~ 1580 cm
-1
, ~ 1350 cm
-1
 and ~ 2680 cm
-1
, respectively. 
ID/IG = 0.35, and the full-width at half maximum (FWHM) of 2D band is 64.15 cm
-1
, 
confirming the few-layer nature of the graphene sample.
[3]
 In addition, the thermal profile for 
FLG (C) is in agreement with a low content of functional groups, revealing a weight loss of only 
6.2% at 600 ºC. Panel (D) displays the elemental analysis of FLG, from which it can be 
concluded that the sample is mostly composed of carbon. A residual melamine content of 0.69 
wt% can be estimated from the atomic content of nitrogen in FLG. 
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Figure S3: (A) TEM revealed a lateral size distribution of SLG in water dispersion between 200 
and 1000 nm, with most of nanosheets around 300 nm. Panel (B) shows Raman spectrum 
(recorded at 532 nm) of graphene deposits prepared by drop-casting SLG in water on silicon 
oxide substrate (average of 10 spectra). Raman spectrum is composed by the typical graphene 
Raman ban s: D ban , G ban , D’ ban  an  2D band, which are centered at ~1345 cm-1, ~1586 
cm
-1
, ~1620 cm
-1
, and ~2681 cm
-1
, respectively. ID/IG = 1.50, and the full-width at half 
maximum (FWHM) of 2D band is 28 cm
-1
, confirming the single-layer nature of the graphene 
sample.
[8] 
(C) XPS profile of SLG as deposited film, without any annealing. The C1s X-ray 
photoelectron spectroscopy analysis of the SLG films shows minor widening on the high-energy 
side of the C1s peak confirming that there is only little functionalization of the graphene carbon 
sheets. Panel (D) displays the elemental analysis of SLG, calculated from the fitting of the XPS 
C1S peak, from which it can be concluded that the sample is mostly composed of carbon. 
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Figure S4: TEM images of (A) FLG and (B) SLG after treating with hMPO for 40 h. Scale bar: 
500 nm.  
 
 
Figure S5. Raman microspectrometric 2D mapping analysis of FLG samples at 0 h (top) and 
after treating with MPO for 40 h, where G band map images (left side) and D/G ratio map (right 
A B
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side) are shown. After treating with MPO for 40 h (bottom), we can observe a reduction in the G 
band intensity, which indicates degradation of the FLG sheets. D/G ratio is also increased 
compared to 0 h FLG sheets. 
 
 
Figure S6. Raman microspectrometric 2D mapping analysis of SLG samples at 0 h (top) and 
after treating with MPO for 40 h, where G band map images (left side) and D/G ratio map (right 
side) are shown. After treating with MPO for 40 h (bottom), we can observe a reduction in the G 
band intensity, which indicates degradation of the SLG sheets. D/G ratio is also increased 
compared to 0 h SLG sheets. 
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Figure S7: Raman spectra of FLG and SLG sheets, respectively, treated for 40 h with H2O2. 
  
 
Figure S8: (A) Gel electrophoresis of MPO alone or MPO incubated with FLG and SLG 
samples. Lane 0: Protein ladder; Lane 1: hMPO alone; Lane 2 & 4: FLG incubated with 
hMPO; Lane 3 & 5: SLG incubated with hMPO. (B) Relative densitometry analysis of the 
hMPO band (146 kDa): the results are expressed relative to the band of hMPO alone which is 
considered as 100 % of intensity. 
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